Active	Status	Sponsor type	Region	Phase	Filter
1 Active 14 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
metformin delayed-release (ANJ900) / Anji Pharma
DREAM-T2D, NCT04854512 / 2020-000763-23: Investigational Study of Delayed Release Metformin	Suspended	3	675	Europe, Canada, US, RoW	Metformin DR, ANJ900, MetDR, Metformin IR, Metformin DR Placebo, Metformin IR placebo	Anji Pharma	Diabetes Mellitus, Type 2	12/23	06/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
metformin delayed-release (ANJ900) / Anji Pharma
DREAM-T2D, NCT04854512 / 2020-000763-23: Investigational Study of Delayed Release Metformin	Suspended	3	675	Europe, Canada, US, RoW	Metformin DR, ANJ900, MetDR, Metformin IR, Metformin DR Placebo, Metformin IR placebo	Anji Pharma	Diabetes Mellitus, Type 2	12/23	06/24